FDA Approves Zurnai and Neffy
The FDA issued notices for certain migraine, acetaminophen, clonazepam, and semaglutide products.
A new naloxone nasal spray will soon be available.
Patients taking this muscle relaxant may be impacted by a lot from Eugia US/AuroMedics Pharma.
As firefighters see more presumptions for heart disease, keeping track of heart medications could grow in importance.
Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.
While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.
The growing demand for this drug has led individuals to search for semaglutide from alternative sources.
Hypersensitivity reactions may start as a rash but can quickly result in injury to internal organs.
The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.
